Section R9-6-387. Vancomycin-Resistant Staphylococcus epider- midis

Case control measures:

1.        A diagnosing health care provider or an administrator of a health care institution, either personally or through a rep- resentative, shall isolate and implement contact precau- tions for a case or suspect case of vancomycin-resistant Staphylococcus epidermidis.

2.        A local health agency shall:

a.        Upon receiving a report under R9-6-202 of a case or suspect case of vancomycin-resistant Staphylococ- cus epidermidis, notify the Department within one working day after receiving the report and provide to the Department the information contained in the report;

b.        Conduct an epidemiologic investigation of each reported case or suspect case of vancomycin-resis- tant Staphylococcus epidermidis;

c.        For each case of vancomycin-resistant Staphylococ- cus epidermidis, submit to the Department, as speci- fied in Article 2, Table 4, the information required under R9-6-206(D); and

d.        Ensure that an isolate from each case of vancomy- cin-resistant Staphylococcus epidermidis is submit- ted to the Arizona State Laboratory.

Historical Note

Section renumbered from R9-6-375 and amended by final rulemaking at 10 A.A.R. 3559, effective October 2, 2004 (Supp. 04-3). Former R9-6-387 renumbered to R9-6-393; new R9-6-387 renumbered from R9-6-381 and amended by final rulemaking at 14 A.A.R. 1502, effective April 1, 2008 (Supp. 08-2).